SUBSCRIBE

Uptake of biosimilars in different countries varies

 Posted 08/11/2019

The uptake of biosimilars in different countries was a subject discussed by both Dr Jaclyn Bosco and Mr Murray Aitken of IQVIA.

more
22119008_l
FDA approves pegfilgrastim biosimilar Ziextenzo Biosimilars/News | Posted 08/11/2019
EC publishes biosimilar information for healthc... Guidelines | Posted 08/11/2019
Biosimilar regulation in the Middle East Reports | Posted 08/11/2019
Clinical data requirements for biosimilars in t... Biosimilars/Research | Posted 08/11/2019
Generics transition brings economic benefits to... Generics/Research | Posted 08/11/2019
Tanvex BioPharma’s filgrastim biosimilar comes... Biosimilars/News | Posted 08/11/2019
Glenmark and Lupin gain FDA approval for nervou... Generics/News | Posted 08/11/2019
Biosimilars regulation in Canada: state of play Biosimilars/Research | Posted 08/11/2019
Considerations for real-world research on biosi... Reports | Posted 08/11/2019
Clinical data requirements for biosimilars in t... Biosimilars/Research | Posted 08/11/2019
16704526_l
US Senators reveal plans to lower drug prices Policies & Legislation | Posted 08/11/2019
Biocon acquires Pfizer research facility and si... Pharma News | Posted 08/11/2019
A call for economic reassessment of drug regimens Generics/Research | Posted 08/11/2019
20920796_l
Bevacizumab ‘similar biologic’ Versavo launched... Biosimilars/News | Posted 08/11/2019
FDA issues final guidance on petitions delaying... Guidelines | Posted 08/11/2019
Pharmacy chain drives choice among US generics... Generics/Research | Posted 25/10/2019
Clinical data requirements for biosimilars in t... Biosimilars/Research | Posted 25/10/2019
22119008_l
EMA approval for Pegfilgrastim Mundipharma Biosimilars/News | Posted 25/10/2019
ST002293
Impact of biologicals on health care Reports | Posted 25/10/2019
16704526_l
UK Labour Party proposes state run generics man... Generics/General | Posted 25/10/2019
AA010964
Positive real-world data for etanercept biosimi... Biosimilars/Research | Posted 25/10/2019
Canada amends its drug pricing regulations Policies & Legislation | Posted 25/10/2019
Lupin to sell Japanese injectables business and... Pharma News | Posted 25/10/2019
Clinical data requirements for biosimilars in t... Biosimilars/Research | Posted 18/10/2019
Russian approval for non-originator dornase alfa Biosimilars/News | Posted 18/10/2019
FDA planning more guidance for developers of co... Guidelines | Posted 18/10/2019
Celltrion and Juno make biosimilars deal in Aus... Biosimilars/General | Posted 18/10/2019
Trial of bevacizumab copy biological with novel... Biosimilars/Research | Posted 18/10/2019
First pregabalin generics approved by FDA Generics/Research | Posted 18/10/2019
Further collaborations formed to penetrate Chin... Pharma News | Posted 18/10/2019
Ranitidine recalls escalate as FDA declares ‘un... Generics/General | Posted 18/10/2019
Medicines for Europe 13th Pharmacovigilance Con... Conferences | Posted 18/10/2019
Medicines for Europe 19th Regulatory and Scient... Conferences | Posted 18/10/2019
Clinical data requirements for biosimilars in t... Biosimilars/Research | Posted 11/10/2019
FDA approves Pfenex’s follow-on teriparatide pr... Biosimilars/News | Posted 11/10/2019
EMA provides guidance on avoiding nitrosamines... Guidelines | Posted 11/10/2019
Biocon/Mylan launch first insulin glargine bios... Biosimilars/News | Posted 11/10/2019
FDA releases new patient guidance on biosimilars Biosimilars/General | Posted 11/10/2019
Adalimumab copy biological shown to be safe and... Biosimilars/Research | Posted 11/10/2019
Strong generics nocebo effect found in US Generics/Research | Posted 11/10/2019
AB004665
Alimta and Orfadin generics approved by FDA Generics/News | Posted 11/10/2019
ST002293
Biosimilars applications reviewed in the EU Biosimilars/Research | Posted 04/10/2019
Three darbepoetin alfa biosimilars approved in... Biosimilars/News | Posted 04/10/2019
Novo Nordisk to launch biosimilar insulin in th... Biosimilars/General | Posted 04/10/2019
iBio and CC-Pharming collaborate for rituximab... Biosimilars/News | Posted 04/10/2019
Switching from originator to biosimilar epoetin... Biosimilars/Research | Posted 04/10/2019
New evidence: comparable clinical outcomes for... Generics/Research | Posted 04/10/2019
Celltrion contracts Lonza to manufacture autoim... Pharma News | Posted 04/10/2019
Carcinogen contamination halts distribution of... Generics/General | Posted 04/10/2019
more

NON-BIOLOGICAL COMPLEX DRUGS

FDA issues final guidance on liposome drug products Posted 27/04/2018

On 4 April 2018, the US Food and Drug Administration (FDA) issued a new draft...

more


FDA approves 40 mg follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 09/03/2018
Mylan launches first follow-on glatiramer aceta... Non‐Biological Complex Drugs/News | Posted 15/02/2018
Biosimilars and follow-on NBCDs for MS in Europ... Non‐Biological Complex Drugs/Research | Posted 19/01/2018
Impax announces FDA approval of follow-on sevel... Non‐Biological Complex Drugs/News | Posted 17/11/2017
FDA approves follow-on version of sevelamer Non‐Biological Complex Drugs/News | Posted 30/06/2017
Challenges in the regulation of NBCDs Non‐Biological Complex Drugs/Research | Posted 12/05/2017
Scientific and regulatory considerations for fo... Non‐Biological Complex Drugs/Research | Posted 05/05/2017
Equivalence of complex drug products Non‐Biological Complex Drugs/Reports | Posted 14/04/2017
Follow-up studies needed to ensure safety for f... Non‐Biological Complex Drugs/Research | Posted 31/03/2017
Warning letter causes delays for follow-on glat... Non‐Biological Complex Drugs/News | Posted 17/03/2017
Is the EU ready for non-biological complex drug... Non‐Biological Complex Drugs/Research | Posted 03/03/2017
Follow-on versions of glatiramer acetate in Rus... Non‐Biological Complex Drugs/News | Posted 24/02/2017
Non-biological complex drugs and pharmacopoeias Non‐Biological Complex Drugs/Research | Posted 10/02/2017
In vitro analysis of follow-on versions of seve... Non‐Biological Complex Drugs/Research | Posted 18/11/2016
Determining the bioequivalence of follow-on iro... Non‐Biological Complex Drugs/Reports | Posted 04/11/2016
FDA to set up abbreviated pathway for complex p... Non‐Biological Complex Drugs/Polices & Legislation | Posted 21/10/2016
Challenges in the assessment of ophthalmic emul... Non‐Biological Complex Drugs/Reports | Posted 07/10/2016
Cancer lab to evaluate bioequivalence of nanosi... Non‐Biological Complex Drugs/News | Posted 23/09/2016
A conference on ‘Equivalence of Complex Drug Pr... Non‐Biological Complex Drugs/News | Posted 09/09/2016
Collaboration to introduce nanotechnologies in... Non‐Biological Complex Drugs/News | Posted 26/08/2016
Iron carbohydrate follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 12/08/2016
Rigorous approach used to approve a follow-on v... Non‐Biological Complex Drugs/Research | Posted 29/07/2016
US guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 10/06/2016
Non-biological complex drugs and their follow-o... Non‐Biological Complex Drugs/Research | Posted 03/06/2016
Is a new pathway for NBCDs on the way in the US? Non‐Biological Complex Drugs/Polices & Legislation | Posted 27/05/2016
Follow-on glatiramer acetate gains European app... Non‐Biological Complex Drugs/News | Posted 13/05/2016
FDA includes follow-on versions in its new cycl... Non‐Biological Complex Drugs/Guidelines | Posted 29/04/2016
Switching between originator and follow-on iron... Non‐Biological Complex Drugs/Research | Posted 22/04/2016
Follow-on intravenous iron formulations in haem... Non‐Biological Complex Drugs/Research | Posted 01/04/2016
Glatiramoid follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/03/2016
FDA includes follow-on versions in its new lipo... Non‐Biological Complex Drugs/Guidelines | Posted 26/02/2016
EU guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 22/01/2016
GDUFA regulatory priorities for 2016 include co... Non‐Biological Complex Drugs/Polices & Legislation | Posted 11/12/2015
Liposomal follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/12/2015
Regulations for follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 13/11/2015
Status and regulatory issues surrounding follow... Non‐Biological Complex Drugs/Reports | Posted 05/11/2015
Follow-on glatiramer acetate (M356) claimed as... Non‐Biological Complex Drugs/Research | Posted 05/11/2015
EMA issues reflection paper for follow-on versi... Non‐Biological Complex Drugs/Guidelines | Posted 05/11/2015
FDA approves first follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 05/11/2015
more

Country Focus

All countries

Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!

Generics News Research General

more

Biosimilars News Research General

more

More editorial sections